Predictive Clinical and Biological Parameters in Breast Cancer

Not Applicable

Recruiting

• Conditions: Breast Cancer
• Interventions: Genetic: molecular alteration

• Registration Number: NCT01521676
• Lead Sponsor: Institut Paoli-Calmettes

Brief Summary

Research of predictive clinical and biological factors in breast cancer :

genomic, proteomic, mutation

Detailed Description

Not available

Study Timeline

• Study Start: 2010-12
• Study First Submitted: 2011-12-22
• Study First Submitted QC: 2012-01-30
• Study First Posted: 2012-01-31
• Status Verified: 2017-09
• Last Update Submitted: 2017-09-01
• Last Update Posted: 2017-09-05
• Primary Completion: 2019-12
• Study Completion: 2029-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 750

Inclusion Criteria

• breast cancer
• age > 18
• signed informed consent

Exclusion Criteria

• emergency

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
breast cancer	molecular alteration	blood and tumor sample

Primary Outcome Measures

Name	Time	Method
molecular alteration in breast cancer	average of 4 weeks after diagnosis	gene expression level

Secondary Outcome Measures

Name	Time	Method
relation between molecular alteration and clinical and histological characteristics	up to 3 years	hazard ratio between molecular alteration and clinical and histological characteristics

Trial Locations

Locations (2)

Hôpital Sainte-Musse; 🇫🇷 Toulon, France

Institut Paoli Calmettes; 🇫🇷 Marseille, France